Source: Pharmaceutics. Unidade: IFSC
Subjects: COVID-19, CORONAVIRUS, PEPTÍDEOS, RESISTÊNCIA MICROBIANA ÀS DROGAS
ABNT
BITENCOURT, Natália Vitória et al. Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein. Pharmaceutics, v. 15, n. 2, p. 436-1-436-17 + supplementary materials: 1-8, 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15020436. Acesso em: 31 ago. 2024.APA
Bitencourt, N. V., Righetto, G. M., Camargo, I. L. B. da C., Godoy, M. O. de, Guido, R. V. C., Oliva, G., et al. (2023). Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein. Pharmaceutics, 15( 2), 436-1-436-17 + supplementary materials: 1-8. doi:10.3390/pharmaceutics15020436NLM
Bitencourt NV, Righetto GM, Camargo ILB da C, Godoy MO de, Guido RVC, Oliva G, Santos Filho NA, Cilli EM. Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein [Internet]. Pharmaceutics. 2023 ; 15( 2): 436-1-436-17 + supplementary materials: 1-8.[citado 2024 ago. 31 ] Available from: https://doi.org/10.3390/pharmaceutics15020436Vancouver
Bitencourt NV, Righetto GM, Camargo ILB da C, Godoy MO de, Guido RVC, Oliva G, Santos Filho NA, Cilli EM. Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein [Internet]. Pharmaceutics. 2023 ; 15( 2): 436-1-436-17 + supplementary materials: 1-8.[citado 2024 ago. 31 ] Available from: https://doi.org/10.3390/pharmaceutics15020436